|Day Low/High||0.53 / 0.57|
|52 Wk Low/High||0.84 / 4.32|
TheStreet's biotech columnist offers his own report card on biotech stocks.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Ampio Pharmaceuticals Inc , where a total of 1,453 contracts have traded so far, representing approximately 145,300 underlying shares. That amounts to about 81.2% of AMPE's average daily trading volume over the past month of 179,045 shares.
When a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.
Trade-Ideas LLC identified Ampio Pharmaceuticals (AMPE) as a weak on high relative volume candidate
Ampio Pharma (AMPE) stock is sharply lower this afternoon following a phase 3 trial for its osteoarthritis pain treatment.
Ampio to request approval from the FDA for the treatment of pain due to severe osteoarthritis of the knee.